Rémi Guillon
3Patents
0h-index
15Co-inventors
28Inventor score
Filing activity: Sep 29, 2014 → May 4, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10626115B2 | Fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US11236093B2 | Adenine derivatives as protein kinase inhibitors | Human Necessities | 0 | Active |
| US9783541B2 | 5′-nucleotidase inhibitors and therapeutic uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.